INTU and lung carcinoma: Once MER65-Int was excluded, the comparable expression change of the 10 remaining biomarker candidates (AluYg6, HERVL18-int, L1MEa, LTR18A, LTR18B, LTR77, MER126, UCON26, UCON34 and UCON80) made them a “suitable set” of biomarker candidates for both lung cancers.